MAPK8 and prostate carcinoma: Meanwhile, the autophagy inhibitor 3‐MA and the JNK‐specific inhibitor SP600125 could inhibit DS‐induced cellular autophagy, suggesting that DS partly inhibits prostate cancer growth by activating the JNK signaling pathway and inducing autophagy.